文献速递神经肿瘤小儿神经外科与脑积水

国际DIPG注册中心影像评估与组织病理诊断准确性对比

Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry.
PubMed 文献 · Neuro Oncol · 2022-01-01

基于国际DIPG注册中心数据,对286例有病理结果的患者分析显示8%组织学诊断不符合DIPG;569例中心影像评估中7%被归类为非DIPG。联合分析151例中,影像典型DIPG者99%病理一致,影像提示替代诊断者仅47%病理不一致,中心影像评估与病理诊断显著相关且可预测总生存。

要点

  • 中心影像评估为典型DIPG时,99%病理符合DIPG。
  • 影像提示替代诊断时,仅47%病理不符合DIPG。
  • 中心影像评估与病理诊断显著相关并可预测总生存。

核心结论

  • 中心神经影像评估在确认DIPG诊断中具有重要价值且准确性高。

研究设计与样本

  • 分析国际DIPG注册中心提交的有组织病理和/或影像数据的病例,由两名神经放射学家对诊断性脑MRI进行中心影像评估。

主要发现

  • 286例有活检和/或尸检病理的患者中,23例(8%)组织学诊断不符合DIPG,最常见为非弥漫性低级别胶质瘤和胚胎性肿瘤。
  • 569例中心评估的诊断性MRI中,40例(7%)被归类为非DIPG、怀疑替代诊断。
  • 联合分析151例中,77例影像典型DIPG者76例(99%)病理符合DIPG(浸润性II-IV级胶质瘤)。
  • 57例影像可能DIPG但有一些不典型特征者55例(96%)病理符合DIPG。
  • 17例影像提示替代诊断者中8例(47%)病理不符合DIPG(其余因非脑桥起源被排除)。

关键数值与推荐

  • 影像提示替代诊断的特征包括:非脑桥起源、脑桥受累<50%、局灶性外生形态、边界清晰和/或弥漫性明显弥散受限。

临床怎么用

  • 对于影像典型DIPG的患儿,中心影像评估可高度确认诊断,支持临床诊断路径。
  • 当影像存在不典型特征或提示替代诊断时,应积极考虑组织活检以明确病理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diffuse intrinsic pontine glioma (DIPG) remains a clinico-radiologic diagnosis without routine tissue acquisition. Reliable imaging distinction between DIPG and other pontine tumors with potentially more favorable prognoses and treatment considerations is essential. METHODS: Cases submitted to the International DIPG registry (IDIPGR) with histopathologic and/or radiologic data were analyzed. Central imaging review was performed on diagnostic brain MRIs (if available) by two neuro-radiologists. Imaging features suggestive of alternative diagnoses included nonpontine origin, <50% pontine involvement, focally exophytic morphology, sharply defined margins, and/or marked diffusion restriction throughout. RESULTS: Among 286 patients with pathology from biopsy and/or autopsy, 23 (8%) had histologic diagnoses inconsistent with DIPG, most commonly nondiffuse low-grade gliomas and embryonal tumors. Among 569 patients with centrally-reviewed diagnostic MRIs, 40 (7%) were classified as non-DIPG, alternative diagnosis suspected. The combined analysis included 151 patients with both histopathology and centrally-reviewed MRI. Of 77 patients with imaging classified as characteristic of DIPG, 76 (99%) had histopathologic diagnoses consistent with DIPG (infiltrating grade II-IV gliomas). Of 57 patients classified as likely DIPG with some unusual imaging features, 55 (96%) had histopathologic diagnoses consistent with DIPG. Of 17 patients with imaging features suggestive of an alternative diagnosis, eight (47%) had histopathologic diagnoses inconsistent with DIPG (remaining patients were excluded due to nonpontine tumor origin). Association between central neuro-imaging review impression and histopathology was significant (p < 0.001), and central neuro-imaging impression was prognostic of overall survival. CONCLUSIONS: The accuracy and important role of central neuro-imaging review in confirming the diagnosis of DIPG is demonstrated.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Lazow MA, Fuller C, DeWire M, et al. Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry. Neuro Oncol. 2022. PMID: 34668975. doi:10.1093/neuonc/noab245

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。